A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment (Review)
2017
Molecular and clinical oncology
In recent years, magnetic nanoparticles (MNPs) have demonstrated marked progress in the field of oncology. General nanoparticles are widely used in tumor targeting, and the intrinsic magnetic property of MNPs makes them the most promising nanomaterial to be used as contrast agents for magnetic resonance imaging (MRI) and induced magnetic hyperthermia. The properties of MNPs are fully exploited when they are used as drug delivery agents, wherein drugs may be targeted to the desired specific
doi:10.3892/mco.2017.1399
pmid:29075487
pmcid:PMC5649002
fatcat:lzkgsthnynb7vhussonabumfwy